North America Clinical Laboratory Services Market - Industry Trends and Forecast to 2028
North America clinical laboratory services market is projected to register a CAGR of 7.3% in the forecast period of 2021 to 2028. The new market report contains data for the historic year 2019, the base year of calculation is 2020 and the forecast period is 2021 to 2028
Market Segmentation
North America Clinical Laboratory Services Market, By Service Type (Routine Testing Services, Esoteric Services, and Anatomic Pathology Services), Specialty (Clinical Chemistry Testing, Hematology Testing, Microbiology Testing, Immunology Testing, Drugs of Abuse Testing, Cytology Testing, and Genetic Testing), Provider (Hospital-Based Laboratories, Independent & Reference Laboratories, Nursing and Physician Office-Based Laboratories), Application (Drug Discovery Related Services, Drug Development Related Services, Bioanalytical & Lab Chemistry Services, Toxicology Testing Services, Cell & Gene Therapy Related Services, Preclinical & Clinical Trial Related Services And Other Clinical Laboratory Service) Industry Trends and Forecast to 2028
Some of the major factors contributing to the growth of the North America clinical laboratory services market are:
• Rise in demand for early and accurate disease diagnosis
• Advancement in clinical diagnostic methods
Market Players
Some of the major players operating in North America clinical laboratory services market are:
• Genomic Health
• Abbott
• Charles River
• H.U. Group Holdings, Inc.
• Eurofins Scientific
• Laboratory Corporation of America Holding
• Mayo Foundation for Medical Education and Research
• DaVita Inc.
• Quest Diagnostics Incorporated
• Siemens Healthcare GmbH
• ARUP Laboratories
• Lifelabs
• BioReference Laboratories, Inc. (A subsidiary of OPKO Health, Inc.)
• NeoGenomics Laboratories, Inc.
• ACM Global Laboratories
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook